Athira Pharma Inc (ATHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
Operating Expenses | 9,079 | 7,397 | 2,252 | 1,267 | 0 |
Operating Income | -9,079 | -7,397 | -2,252 | -1,267 | N/A |
Other Income | 1,377 | -1,059 | 260 | -538 | 0 |
Pre-tax Income | -7,702 | -8,456 | -1,992 | -1,805 | 0 |
Net Income Continuous | -7,702 | -8,456 | -1,992 | -1,805 | N/A |
Net Income | $-7,702 | $-8,456 | $-1,992 | $-1,805 | $N/A |
EPS Basic Total Ops | 0.41 | -1.12 | -0.48 | -0.48 | N/A |
EPS Basic Continuous Ops | 0.41 | -1.12 | -0.48 | -0.48 | N/A |
EPS Diluted Total Ops | 0.41 | -1.12 | -0.48 | -0.48 | N/A |
EPS Diluted Continuous Ops | 0.41 | -1.12 | -0.48 | -0.48 | N/A |
EBITDA(a) | $-8,912 | $-7,397 | $-2,252 | $-1,095 | $N/A |